A study by Yi et al. demonstrated the presence of the TMPRSS2:ERG gene fusion in 45.16% of patients with prostate cancer, while it was not found in patients with benign prostatic hyperplasia or in cell lines. This evidence concerns the gene ERG and Familial prostate cancer.